Medigene AG buy MoneyMoney
Start price
05.09.17
/
50%
€13.67
Target price
24.01.18
€17.00
Performance (%)
25.09%
End price
24.01.18
€17.10
Summary
This prediction ended on 24.01.18 with a price of €17.10. The BUY prediction by MoneyMoney finished with a performance of 25.09%. MoneyMoney has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medigene AG | - | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % | 48,88 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % | 83,74 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % | 60,39 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % | 61,27 % |
According to MoneyMoney what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Significant cyclical dependencies
Comments by MoneyMoney for this prediction
In the thread Medigene AG diskutieren
Medigene
Übernahmefantasie bei den Biotech - Aktien ...
Stopped prediction by MoneyMoney for Medigene AG
Medigene AG
Start price
Target price
Perf. (%)
€3.79
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-45.05%
23.02.23
23.02.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€14.12
09.04.18
09.04.18
€20.00
18.11.19
18.11.19
-58.75%
18.11.19
18.11.19
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€8.96
10.01.16
10.01.16
€13.00
28.12.16
28.12.16
33.93%
28.12.16
28.12.16
Could be worthwhile Investment >10% per year
Significant cyclical dependencies